New shot aims to tame blood disorders
Disease control
Recruiting now
This early-stage trial tests a new drug called OM336 for people with autoimmune cytopenias, where the immune system attacks blood cells. The study includes 32 adults with conditions like immune thrombocytopenia (ITP) or autoimmune hemolytic anemia (AIHA) who have not responded to…
Phase: PHASE1 • Sponsor: Ouro Medicines • Aim: Disease control
Last updated May 13, 2026 16:03 UTC